Revelation Biosciences Files Prospectus For The Resale Of 4,272,500 Shares Via Warrants For Potential Proceeds Up To ~$14.7M

Revelation Biosciences, Inc.

 

4,272,500 Shares of Common Stock

 

This prospectus relates to the resale, from time to time, of up to 4,272,500 shares of common stock, par value $0.001 per share, by the selling stockholders identified in this prospectus under "Selling Stockholders" (the "Selling Stockholders") to be issued upon the exercise of common stock purchase warrants (the "Class J Common Stock Warrants") pursuant to an inducement offer letter agreement the Company entered into with the Selling Stockholders on January 23, 2026 (the "Inducement Letter"). The Class J Common Stock Warrants are exercisable after and for five years from the date of stockholder approval at an exercise price of $3.44 per share. We are not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale of the shares of common stock. We may, however, receive proceeds from any warrants that are exercised through the payment of the exercise price in cash, in a maximum amount of up to approximately $14,697,400. We are paying however all of the fees and expenses in connection with the registration of the shares of common stock.

Our common stock is listed on the Nasdaq Capital Market under the symbol "REVB." On January 26, 2026, the last reported sale price of our common stock on the Nasdaq Capital Market was $2.20.